Tag Archives: VINC

Vincerx Pharma (NASDAQ:VINC) Receives New Coverage from Analysts at Laidlaw

Laidlaw started coverage on shares of Vincerx Pharma (NASDAQ:VINC) in a research report sent to investors on Monday morning, Analyst Ratings Network reports. The firm issued a buy rating and a $30.00 price target on the stock.

Several other brokerages have also recently commented on VINC. Chardan Capital reduced their price target on Vincerx Pharma from $33.00 to $30.00 and set a buy rating for the company in a research report on Friday, August 13th. B. Riley started coverage on Vincerx Pharma in a report on Wednesday, August 25th. They issued a buy rating and a $26.00 price objective....More>>>

Vincerx Pharma (NASDAQ:VINC) Receives New Coverage from Analysts at Laidlaw

Laidlaw started coverage on shares of Vincerx Pharma (NASDAQ:VINC) in a research report sent to investors on Monday morning, Analyst Ratings Network reports. The firm issued a buy rating and a $30.00 price target on the stock.

Several other brokerages have also recently commented on VINC. Chardan Capital reduced their price target on Vincerx Pharma from $33.00 to $30.00 and set a buy rating for the company in a research report on Friday, August 13th. B. Riley started coverage on Vincerx Pharma in a report on Wednesday, August 25th. They issued a buy rating and a $26.00 price objective....More>>>